Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • AVITA Medical to collaborate with Regenity Biosciences to expand their skin regeneration portfolio
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • AVITA Medical to collaborate with Regenity Biosciences to expand their skin regeneration portfolio
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • AVITA Medical to collaborate with Regenity Biosciences to expand their skin regeneration portfolio
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • AVITA Medical to collaborate with Regenity Biosciences to expand their skin regeneration portfolio
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • AVITA Medical to collaborate with Regenity Biosciences to expand their skin regeneration portfolio
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • AVITA Medical to collaborate with Regenity Biosciences to expand their skin regeneration portfolio
    AVITA Medical to collaborate with Regenity Biosciences to expand their skin regeneration portfolio
    • News

  • Former Big Pharma VP takes helm of Syntara Board, accelerates cancer drug development
    Former Big Pharma VP takes helm of Syntara Board, accelerates cancer drug development
    • News

  • This small cap biotech is working with Professor Fiona Wood to unscar skin scars, and mainstream media is taking note
    This small cap biotech is working with Professor Fiona Wood to unscar skin scars, and mainstream media is taking note
    • News

  • “Scars are more than skin deep”: Why Professor Fiona Wood is working with this biotech to melt away scars
    “Scars are more than skin deep”: Why Professor Fiona Wood is working with this biotech to melt away scars
    • News

  • Spray On Skin available to over 200,000 more US healthcare providers following purchasing agreement
    Spray On Skin available to over 200,000 more US healthcare providers following purchasing agreement
    • News

  • UNITH prepares for public launch of Digital Human Platform with major website upgrade
    • News

    UNITH prepares for public launch of Digital Human Platform with major website upgrade

    A public launch of the Digital Human platform is edging closer with artificial intelligence company UNITH (ASX: UNT) rolling out a major website upgrade, designed for integration of their platform that will make AI-powered digital humans accessible to all business owners.  The recent unveiling of unith.ai demonstrates a range of embedded digital humans that showcase

    Read More
    Public
  • IG study shows ASX traders most bullish since January 2022
    • News

    IG study shows ASX traders most bullish since January 2022

    The continuous high of S&P/ASX 200 is spreading a contagious bullish attitude among local traders. New research from global financial technology company IG released finds that although traders in Australia continue to favour commodities and indices, they are actively exploring other financial markets under improving conditions.  The ‘A Trader’s Position’ Report – informed by IG’s

    Read More
    Public
  • MedAdvisor reports strong quarter thanks to US vaccine programs and Aus transaction fees
    • News

    MedAdvisor reports strong quarter thanks to US vaccine programs and Aus transaction fees

    Following a notable US performance, integrating conversational AI and increased pharmacy transaction fees in Australia, medication management platform MedAdvisor Solutions (ASX: MDR) has reported a strong third quarter in FY24.  The December to February period in the US is typically the flu season, placing importance on getting vaccinated. This proved beneficial for MedAdvisor. In the

    Read More
    Public
  • Zoono secures first UK supermarket customer for shelflife extension tech with OSY
    • News

    Zoono secures first UK supermarket customer for shelflife extension tech with OSY

    About a third of all food produced is lost or wasted yearly. Besides painting a grim picture of world hunger, this is also responsible for harmful emissions.  Tackling food waste, global biotech company Zoono (ASX: ZNO) has teamed up with England-based hygiene tech company OSY to distribute a tech that boosts the shelf-life of produce. 

    Read More
    Public
  • Distributed energy resource management systems – what are they?
    • News

    Distributed energy resource management systems – what are they?

    According to TechSci Research report, “Distributed Energy Resource Management System Market – Global Industry Size, Share, Trends, Opportunity, and Forecast 2018-2028F”, the global distributed energy resource management system market is expected to register 15.48% CAGR during the forecast period, owing to rising government initiatives for residential buildings, power consumption, and the demand for effective energy management systems that maintain

    Read More
    Public
  • Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season
    • News

    Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season

    Flu season is around the corner, typically affecting us between May and September. Just in time for that, Australian global molecular diagnostics company Genetic Signatures (ASX: GSS) is gearing up to launch its modified respiratory kit in the country. The Company reported that the Therapeutic Goods Administration (TGA) has completed the review of its redesigned

    Read More
    Public
  • Felix awarded new contracts as supply chain reporting becomes mandatory
    • News

    Felix awarded new contracts as supply chain reporting becomes mandatory

    SaaS-based vendor marketplace Felix Group (ASX: FLX) reported a strong sales quarter, with five new contractors added and three contract expansions in Q3 FY24. As supply-chain reporting and compliance practices become mandatory, services like Felix’s – where all interactions are imprinted online – become crucial.  The new contract wins and expansions added $407k of new

    Read More
    Public
  • Booktopia reports soft quarter after Black Friday season as Aussies opt for more cost-effective literature
    • News

    Booktopia reports soft quarter after Black Friday season as Aussies opt for more cost-effective literature

    Young Australians’ reading habits leave plenty to be desired. A 2024 study found that one in three Australians is struggling to read, costing the economy billions of dollars and painting a bleak picture for online booksellers like the Booktopia Group (ASX: BKG). The Company has been reeling under the impact of declining interest in books,

    Read More
    Public
  • Vection secures $500k contracts for extended reality naval maintenance tech
    • News

    Vection secures $500k contracts for extended reality naval maintenance tech

    Some food for thought: if the Titanic was built with artificial intelligence (AI) expertise, would it have met the same fate? Would it have been dubbed the “unsinkable” ship at all? Simulations, digital twins of ships, better employee training and more are all made possible in the extended reality (XR) realm. This is what software

    Read More
    Public
  • Xpon’s MarTech products result in new clients and greater margins, new board to helm growth
    • News

    Xpon’s MarTech products result in new clients and greater margins, new board to helm growth

    As artificial intelligence (AI) becomes central to most industries, AI marketing tech company Xpon Technologies (ASX: XPN) is ensuring it finds its place in the spotlight. To do so, the Company – which integrates data and AI to automate marketing processes – has onboarded new board members and clients.  In Q3 FY24, Xpon’s MarTech revenue

    Read More
    Public
  • «
  • ‹
  • 44
  • 45
  • 46
  • 47
  • 48
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.